Scientists disentangle the cycle that makes virus irresistible Kumar Jeetendra | January 9, 2021 Researchers have for the first time identified how viruses like the poliovirus and the common cold virus’package up’ their genetic code, allowing them to infect cells. The findings, published today (Friday, 8 January) in the journal PLOS Pathogens by a team from the Universities of Leeds and York, open up the possibility that medication or …
Gene therapy can viably treat mice with tuberous sclerosis complex, shows study Kumar Jeetendra | January 9, 2021 Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in several organs of the body, have limited treatment choices. A team led by investigators at Massachusetts General Hospital (MGH) has shown that gene therapy can effectively treat mice that express one of the mutated genes that cause the disease. …
Lupin gets USFDA gesture to market generic of sulfamethoxazole, trimethoprim Kumar Jeetendra | January 10, 2021 New Delhi, Jan 6 (PTI) Homegrown pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic version of sulfamethoxazole and trimethoprim oral suspension used in the treatment of bacterial infections. Sulfamethoxazole and trimethoprim oral suspension, 200 mg/40 mg per 5 mL, is indicated for the …
Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US Kumar Jeetendra | January 10, 2021 New Delhi, Jan 10 (PTI) Drug major Cipla is recalling more than 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market, as per a report from the US Food and Drug Administration. The medication major is recalling esomeprazole magnesium for delayed-release oral suspension in unit …
FDA cautions medical services suppliers and clinical lab staff about SARS-CoV-2 viral transformation Kumar Jeetendra | January 10, 2021 The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA is monitoring the potential effect of viral mutations, including an emerging version from the United Kingdom known as the B.1.1.7 variant, on approved SARS-CoV-2 molecular tests, which false negative results can occur with almost any molecular test …
Biomarkers can foresee how hereditarily identical cells act distinctively under pressure Kumar Jeetendra | January 10, 2021 A set of biomarkers not traditionally associated with cell fate can accurately forecast how genetically identical cells behave differently under pressure, according to a UT Southwestern study. The findings, published by Cell Reports as a Dec. 1 cover story, could eventually result in more predictable responses to pharmaceutical remedies. Groups of the same types of …
BioNTech focuses on 2 billion COVID-19 immunization dosages in 2021 Kumar Jeetendra | January 11, 2021 German COVID-19 vaccine maker BioNTech, spouse of US pharmaceutical group Pfizer, said on Monday that it aims to produce two billion doses of its vaccine this year “We now believe we could potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” BioNTech stated in a …
Researchers arrive at significant achievement in leishmaniasis immunization advancement Kumar Jeetendra | January 11, 2021 Scientists have taken an important step forward in creating a controlled human infection model to test leishmaniasis vaccines. The University of York-led study identified and characterized a new strain of Leishmania parasite that will form the basis of a new controlled human infection model for the disease which is transmitted by the bite of sand …
Scientists gives better comprehension of how antibiotic resistance emerges Kumar Jeetendra | January 11, 2021 Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria may have’side-effects’ for them including affecting their ability to induce disease. Antibiotic resistance is still one of the best challenges to global health with very few new antibiotics and widespread immunity. It’s been estimated that …
Dr Reddy’s’ dispatches generic medication in the US market Kumar Jeetendra | January 11, 2021 New Delhi, Jan 11 (PTI) Dr Reddy”s Laboratories on Monday said it has launched Febuxostat tablets, used to treat gout due to high uric acid levels, in the US market. The company has launched the product, which is a generic version of Teijin Ltd”s Uloric tablets, after getting approval from the US Food and Drug …
Speeding Up the Development of Degradable Polymers Kumar Jeetendra | January 11, 2021 Asynt has supplied Polymer Mimetics (Liverpool, UK) with a range of synthetic chemistry equipment to exploit novel chemistries to produce a new generation of high-performance polymers. Polymer Mimetics is a joint venture between the University of Liverpool, and Scott Bader Company Ltd. building upon a new polymerisation process developed by Professor Steve Rannard from the …
Bharat Biotech dispatches first consignment of Covaxin; Kolkata gets the most noteworthy doses of Covishield Kumar Jeetendra | January 12, 2021 Bharat Biotech, which has received Emergency Use Authorisation approval from the Drug Controller General of India for its COVID-19 vaccine Covaxin, is set to dispatch it from the Rajiv Gandhi International Airport on January 12, in the day, a senior official of the Airports cargo branch told news agency PTI. “Today we have received the …
